Safety and Pharmacology of Stanate

Clinical trial NCT00115544 · COMPLETED

Trial details

NCT number: NCT00115544
Sponsor: InfaCare Pharmaceuticals Corporation, a Mallinckrodt Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hyperbilirubinemia

Start date: 2005-09-01
Primary completion: 2006-07-01
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.